.Nature Medication, Posted online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medicine conjugate (ADC) tisotumab vedotin caused improved progression-free and also overall survival, triggering FDA commendation and a brand-new therapy possibility for patients.